Leading the development and commercialization of innovative IVD companion diagnostics that empower personalized healthcare decisions.
We stand at the forefront of the IVD companion diagnostics industry, providing critical tools for pharmaceutical companies and clinicians alike. Our offerings span a broad range of therapeutic areas, accelerating biomarker discovery and enhancing clinical trial efficiency.
Our technological prowess lies in our proprietary assay development platforms and bioinformatics capabilities. We deliver high-sensitivity, high-specificity assays, coupled with robust data analytics, enabling accurate patient stratification and treatment response prediction. ivd companion diagnostics
Driving innovation through integrated solutions, advanced technology and unparalleled expertise.
Expertise in designing, optimizing, and validating highly sensitive and specific IVD assays for a variety of biomarkers.
Advanced data analytics pipelines for biomarker identification, patient stratification, and treatment response prediction.
Rigorous clinical validation studies to demonstrate assay performance and clinical utility.
Visualizing the efficacy and precision of our diagnostic solutions.
Detailed specifications for our IVD companion diagnostic assays.
Demonstrating the clinical and economic value of our IVD companion diagnostics.
Our assay enabled precise patient stratification, leading to a 30% increase in enrollment rates and accelerated trial timelines.
Our assay identified patients most likely to respond to a novel immunotherapy, leading to improved clinical outcomes.
Implementation of our assay improved diagnostic accuracy in cardiovascular disease, reducing false positives and improving patient care.
Our platform facilitated the identification of novel biomarkers for early detection of neurodegenerative diseases.
Our assay integration into their existing workflow reduced turnaround time and increased efficiency.
Our companion diagnostic assisted in the identification of patients most likely to benefit from a new drug candidate, accelerating development.
Powering advancements across diverse healthcare sectors.
Precision diagnostics for cancer treatment selection and monitoring, enhancing response rates and improving patient outcomes.
Early detection of cardiovascular risk factors and personalized management of heart disease.
Diagnosis and monitoring of neurodegenerative diseases and personalized treatment strategies.
Rapid and accurate diagnosis of infectious agents for timely treatment interventions.
Predicting drug response based on individual genetic profiles, optimizing treatment efficacy and minimizing adverse effects.
Accelerating diagnosis and enabling personalized treatment for rare and genetic disorders.
Our quality management system is certified to ISO 13485 standards, ensuring consistent product quality and regulatory compliance.
We implement rigorous quality control procedures throughout the entire manufacturing process, from raw material sourcing to finished product release.
Our regulatory team ensures compliance with all applicable regulations, including FDA, CE marking, and other international standards.
Commitment to quality, accuracy, and reliability.
Expert answers to common technical and commercial inquiries.
Partner with us to accelerate your drug development program and deliver personalized medicine to patients.